Hangzhou Aichek Medical Technology Co.,Ltd

Hangzhou Aichek Medical Technology Co.,Ltd

Manufacturer from China
Active Member
4 Years
Home / Products / Infectious Disease Rapid Test Kits /

99.9% Dengue NS1 Rapid Test Infectious Disease Rapid Test Kits

Contact Now
Hangzhou Aichek Medical Technology Co.,Ltd
City:hangzhou
Province/State:zhejiang
Country/Region:china
Contact Person:MrEdward YU
Contact Now

99.9% Dengue NS1 Rapid Test Infectious Disease Rapid Test Kits

Ask Latest Price
Video Channel
Brand Name :Aichek
Model Number :DEN-A01
Certification :CE
Place of Origin :China
MOQ :5000 Test
Price :negotiable
Payment Terms :T/T
Supply Ability :negotiable
Packaging Details :40box/carton
Storage :2℃-30℃
Sample Type :Blood
User :Professional
Accuracy :99.6% (97.7%-99.9%)
Certificate :CE ISO 13485
OEM :OEM customized packing avaliable
Formats :25T/box 1T/box
After-sales Service :Available
Key words :Dengue NS1 Rapid Test
For the crowd :Preliminary screening of infected people
more
Contact Now

Add to Cart

Find Similar Videos
View Product Description

Infection Disease Dengue NS1 Rapid Test with CE certificate Test Device

Product Name

Dengue NS1 Rapid Test

Formats Strip(3mm)Device(4mm)
Place of Origen China
Specimen Blood
Read Time 15 minutes
Shelf life 2 years
Package 25 device/box or 50 strip/Box
Storage 2℃-30℃

For professional in vitro diagnostic use only.

INTENDED USE

The Dengue NS1 Rapid Test Device is a lateral flow chromatographic immunoassay for the qualitative detection of dengue virus antigen (Dengue Ag) in human whole blood, serum or plasma. It is intended to be used as a screening test and as an aid in the diagnosis of infection with Dengue viruses. Any reactive specimen with the Dengue NS1 Rapid Test Device must be confirmed with alternative testing method(s) and clinical findings.

SUMMARY AND EXPLANATION OF THE TEST

Dengue viruses, a family of four distinct serotypes of viruses (Den 1,2,3,4), are single-strained, enveloped, positive-sense RNA viruses. The viruses are transmitted by mosquitoes of the daytime-bitting Stegemyia family, principally Aedes aegypti, and Aedes albopictus. Today, more than 2.5 billion people living in the areas of tropical Asia, Africa, Australia, and the Americas are at risk for dengue infection. An estimated 100 million cases of dengue fever and 250,000 cases of life-threatening dengue hemorrhagic fever occur annually on a worldwide basis1-3.

Serological detection of IgM antibody is the most common method for the diagnosis of dengue virus infection. Lately, detection of antigens released during virus replication in the infected patient showed very promising result. It enables diagnosis from the first day after the onset of fever up to day 9, once the clinical phase of the disease is over, thus allows early treatment in placed promptly4.

The Dengue NS1 Rapid Test is developed to detect circulating dengue antigen in human whole blood, serum or plasma. The test can be performed by untrained or minimally skilled personnel, without laboratory equipment.

PERFORMANCE CHARACTERISTICS

Clinical Performance

A total of 114 patient samples from susceptible subjects were tested by the Dengue NS1 Rapid Test and by a commercial EIA. Comparison for all subjects is showed in the following table:

Dengue NS1 Rapid Test
Dengue Ag EIA Test Positive Negative Total
Positive 66 3 69
Negative 2 43 45
Total 68 46 114

Relative Sensitivity: 95.6%, Relative Specificity: 95.5%, Overall Agreement: 95.6%

Inquiry Cart 0